Nerve damage from paclitaxel in breast cancer patients
Part of Brain & nervous system, Cancer, Skin clinical trials.
This study looks at how paclitaxel chemotherapy may affect the nerves in the hands and feet (peripheral neuropathy) in women with early breast cancer. It aims to find early signs of nerve damage, understand risk factors, and track how it impacts your daily life and lifestyle.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with early-stage breast cancer (has not spread) and recently had surgery.
- You will receive a chemotherapy drug called paclitaxel (Taxol) after your surgery.
- You have not had prior chemotherapy except for two specific drugs (cyclophosphamide and epirubicin).
- You can walk and do daily activities with little or no help (ECOG score 0-1).
- You are willing and able to follow study instructions and give your written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
This study looks at whether a common chemotherapy drug called paclitaxel (Taxol) causes nerve damage (peripheral neuropathy) in people with advanced stomach cancer. The goal is to find out who is most likely to get this side effect, so doctors can better protect patients during treatment.
This study tests whether wearing cold gloves and socks during paclitaxel chemotherapy can prevent or reduce nerve damage in the hands and feet, a common side effect. If you are getting weekly paclitaxel for breast cancer, this might help keep your hands and feet more comfortable.
This trial tests whether wearing tight surgical gloves during paclitaxel chemotherapy can prevent nerve damage (neuropathy) in the hands. It's for people with stage II or III breast cancer who are about to start paclitaxel treatment for at least 12 weeks.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) can reduce nerve pain caused by the chemotherapy drug nab-paclitaxel in breast cancer patients. It may help women who have finished chemo and are still dealing with numbness, tingling, or pain in their hands or feet.
This study looks at mild or no nerve damage in the hands and feet after breast cancer chemotherapy. Researchers want to understand this condition better and find ways to help.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.